Tesolato, SofíaGonzález-Gamo, DanielBarabash Bustelo, AnaClaver, PaulaDe La-Serna Esteban, Sofía CristinaDomínguez Serrano, María InmaculadaDziakova, JanaJuan Chocano, María Del Carmen DeTorres García, Antonio JoséIniesta Serrano, María PilarSterpetti, Antonio V.2023-12-202023-12-202023-06-24Tesolato, S.E.; González-Gamo, D.; Barabash, A.; Claver, P.; de la Serna, S.C.; Domínguez-Serrano, I.; Dziakova, J.; de Juan, C.; Torres, A.J.; Iniesta, P. Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the BodyMass Index. Cancers 2023, 15, 3324. https://doi.org/10.3390/ cancers151333242072-669410.3390/cancers15133324https://hdl.handle.net/20.500.14352/91602Colorectal cancer (CRC) is one of the main tumor pathologies in our society considering its incidence and mortality. Various authors have linked the development of CRC with overweight and obesity. However, no molecular markers have been defined to connect both pathologies and that can be assessed in serum for diagnostic and/or prognostic purposes. The main objective of this work is to analyze and correlate the expression levels of four miRNAs previously associated with cancer and/or obesity in patients affected by CRC, as well as in a control group without cancer, considering the body mass index (BMI) of subjects. The main novelty of this study consists in the variety of samples investigated: adipose tissues, omental and subcutaneous; serum; and tumor and non-tumor tissues in the case of CRC patients. Results conclude about the utility mainly of hsa-miR-143-3p and hsa-miR-181a-5p in the clinical management of CRC.engAttribution 4.0 Internationaljournal articlehttps://doi.org/10.3390/cancers15133324open access577.2616.348-089Colorectal CancerAdipose tissuemiRNAsSerum biomarkersObesityBiología molecular (Farmacia)EndocrinologíaCirugíaDietética y nutrición (Farmacia)24 Ciencias de la Vida2407 Biología celular